A new study has found that men ages 55 and above who have got less scores on their first standard screening to detect prostate cancer get the least benefit from a repeat test.
The study results were released today from the journal Cancer and showed that for those who have the lowest baseline levels of prostate-specific antigen, or PSA, 24,642 men would needed to be screened and 724 cases of prostate cancer would have to be treated to save one person from dying.
New proofs have been added by this study to a debate about how to screen for prostate cancer to catch tumors at an early stage while missing out on false positives which initiate unnecessary tests and treatment.
Otis Brawley, chief medical officer of the American Cancer Society in Atlanta said in a September 10 interview, “This paper suggests that a man with a low PSA at the age of 50 to 55, even if he were to develop cancer, is not likely to have one of the cancers that’s likely to be harmful. We are starting to realize that there are men who don’t benefit from treatment, especially intensive screening.”